About Epicore BioNetworks (CVE:EBN)
Epicore BioNetworks Inc. develops, manufactures, and markets specialty biotechnology, biochemical, and nutrition products for use in aquaculture, agriculture, waste water treatment, bioremediation, and cleaning industries worldwide. It provides EPICIN branded biological aquaculture systems. The company also offers agriculture products, such as EPIZYM-AW and EPIZYM-PIGS, which are used to liquefy and deodorize animal waste; PHYTOZYM 2-2-2 liquid foliar spray and seed treatment; EPITHATCH biological thatch digester; and EPITHERM microbial ecosystem for composting organic waste. In addition, it provides municipal products, including LINEBAC, a microbial ecosystem to biodegrade contaminants in industrial and municipal wastewater collection systems; LIPOSOLVE municipal emulsifier; DEOBAC biological deodorizer and odor neutralizer; GREASE-X aqueous cleaner and degreaser that penetrates and softens various forms of grease, fats, and oil; and EPIZYM DP-1026, a dry fine granule for municipal collection line and wastewater treatment. Further, the company offers wastewater treatment products comprising EPIZYM-100 microbial ecosystem for the biodegradation of industrial and municipal wastewater; and EPIZYM-200 microbial inoculant for the biodegradation of crude oil and petroleum products. Additionally, it provides biological cleaning and bioremediation products. Epicore BioNetworks Inc. serves farmers, hatchery managers, waste water treatment plant operators, municipalities, and cleaning companies directly, as well as through specialty distributors. The company was formerly known as Epicore Networks Inc. and changed its name to Epicore BioNetworks Inc. in 2000. Epicore BioNetworks Inc. was incorporated in 1987 and is headquartered in Eastampton, New Jersey.
Industry, Sector and Symbol
Industry Pollution & Treatment Controls
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity9.58%
Return on Assets8.32%
Frequently Asked Questions for Epicore BioNetworks (CVE:EBN)
What is Epicore BioNetworks' stock symbol?
Epicore BioNetworks trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EBN."
When will Epicore BioNetworks make its next earnings announcement?
Who are some of Epicore BioNetworks' key competitors?
Some companies that are related to Epicore BioNetworks include Atacama Pacific Gold (ATM), Ikkuma Resources Corp. (IKM), Africa Energy Corp (AFE), Atico Mining (ATY), Pan Orient Energy Corp. (POE), Strategic Oil & Gas (SOG), Orosur Mining (OMI), C-Com Satellite Systems (CMI), CRH Medical Corp (CRM), Aveda Transportation and Energy Services (AVE), Avante Logixx (XX), Energold Drilling Corp (EGD), Sterling Resources (SLG), Abcourt Mines (ABI), Crown Point Energy (CWV), Alderon Iron Ore Corp (ADV), New Zealand Energy Corp. (NZ) and Hyperion Exploration Corp (HYX).
Who are Epicore BioNetworks' key executives?
Epicore BioNetworks' management team includes the folowing people:
- William P. Long, President, Chief Executive Officer, Chief Operating Officer, Director (Age 62)
- Russell Rosenzweig, Chief Financial Officer, Company Secretary (Age 1)
- Robert Stephen Poulton, Non-Executive Chairman of the Board (Age 55)
- Donald R. Siemens, Director
- Stefan Zaphiriou Zarifi, Director
- Alan C. Savage, Independent Director
How do I buy Epicore BioNetworks stock?
Shares of Epicore BioNetworks and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Epicore BioNetworks' stock price today?
One share of Epicore BioNetworks stock can currently be purchased for approximately C$1.30.
How big of a company is Epicore BioNetworks?
Epicore BioNetworks has a market capitalization of C$34.05 million.
How can I contact Epicore BioNetworks?
Epicore BioNetworks' mailing address is 4 Lina Ln, EASTAMPTON, NJ 08060-5414, United States. The company can be reached via phone at +1-609-2679118.
MarketBeat Community Rating for Epicore BioNetworks (EBN)MarketBeat's community ratings are surveys of what our community members think about Epicore BioNetworks and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Epicore BioNetworks (CVE:EBN) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for Epicore BioNetworks (CVE:EBN)
Analysts' Ratings History for Epicore BioNetworks (CVE:EBN)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Epicore BioNetworks (CVE:EBN)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Epicore BioNetworks (CVE:EBN)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Epicore BioNetworks (CVE:EBN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Epicore BioNetworks (CVE EBN)
No insider trades for this company have been tracked by MarketBeat.com
Latest Headlines for Epicore BioNetworks (CVE EBN)
No headlines for this company have been tracked by MarketBeat.com
Financials are not available for this stock.
Epicore BioNetworks (CVE EBN) Chart for Thursday, November, 23, 2017